| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neoleukin Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 11 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NGNE | Neoleukin Therapeutics, Inc. | 11 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 17:37 |